Orchestra BioMed Inc. (OBIO)
4.12
-0.57 (-12.15%)
At close: Mar 03, 2025, 3:59 PM
4.10
-0.49%
After-hours: Mar 03, 2025, 04:00 PM EST
Orchestra BioMed Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
15.5
Upside
276.20
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Date |
Matt Miksic (1.87)
| Barclays | Buy | Initiates | 16 | Jan 2, 2025 |
Yi Chen (0)
| HC Wainwright & Co. | Buy | Reiterates | 14 14 | Nov 15, 2024 |
Keay Nakae (0.31)
| Chardan Capital | Buy | Maintains | 20 20 | Nov 13, 2024 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.